Keyword: Mylan

News

DCAT Announces New Board of Directors

02.11.2018 - Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to...

News

FDA Approves Teva’s Generic EpiPen

23.08.2018 - After two years of trying, Israeli generics producer Teva Pharmaceutical Industries has finally gained approval by the US Food and Drug Administration (FDA) for its copy of Mylan’s...

News

Pfizer Under Pressure in EpiPen Shortage

04.06.2018 - Mylan is leaning on Pfizer to do more to relieve shortages of the EpiPen Auto-Injector. Although the drugmaker based in the US and the UK owns the rights to the EpiPen, which is...

News

Mylan and Fujifilm arm Join up on Biosimilar

26.04.2018 - Mylan has joined forces with Japan’s Fujifilm Kyowa Kirin Biologics to commercialize a biosimilar to Abbvie’s Humira (adalimumab) that has been developed by the Japanese company...

News

FDA Approves Mylan’s Herceptin Biosimilar

07.12.2017 - The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...

News

Teva Realigns, may Slash 25% of Workforce

04.12.2017 - Kåre Schultz, new chief executive officer of debt-plagued Israeli drugmaker Teva, is moving rapidly to make good on his pledge to improve the company’s financial performance and...

News

Sanofi Charges Mylan With Lantus Breach

07.11.2017 - Sanofi is pursuing another US competitor for alleged breach of the patent for its top-selling diabetes drug insulin glargine (branded as Lantus and Lantus SoloStar), which together...

News

Indivior Settles Patent Dispute with Mylan

28.09.2017 - UK-based specialty pharmaceuticals company Indivior, formerly part of Reckitt Benckiser, has reached an-out of-court settlement with Mylan Pharmaceuticals, which was planning to...